According to a recent article in MD Magazine, scientists at a private research company have made significant progress toward the development of an oral flu vaccine. As stated in the article, the researchers at Vaxart, Inc., “have found that an oral tablet for influenza vaccination can protect against infection just as well as – if not better than – a commercial injectable quadrivalent influenza vaccine.”

The oral flu vaccine recently underwent Phase 2 clinical trials, reportedly with very favorable results. MD Magazine reports that: Continue reading →